Feasibility of a rapid protocol of 1-day single-isotope rest/adenosine stress Tc-99m sestamibi ECG-gated myocardial perfusion imaging

Journal of Nuclear Cardiology

Volumn 15, Issue 1, 2008, Pages 35-41

  Tadehara, Futoshi ^a   Yamamoto, Hideya ^a   Tsujiyama, Shuji ^b   Hinoi, Toshihide ^b   Matsuo, Shusuke ^b   Matsumoto, Naoya ^c   Sato, Yuichi ^c   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kure Kyosai Hospital   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

myocardial perfusion imaging; pharmacologic stress; Technetium 99m sestamibi

Indexed keywords

ADENOSINE; DRINKING WATER; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGED; ARTICLE; ARTIFACT; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG MEGADOSE; ELECTROCARDIOGRAM; FEMALE; GATED IMAGING; HEART INFARCTION; HEART SCINTISCANNING; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHARMACOLOGIC STRESS TESTING; PREDICTION; PRIORITY JOURNAL; REST; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOSINE; AGED; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38649109875     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.10.005     Document Type: Article

References (23)

1. Klocke F.J., Baird M.G., Lorell B.H., Bateman T.M., Messer J.V., Berman D.S., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 42 (2003) 1318-1333
2. Hesse B., Tagil K., Cuocolo A., Anagnostopoulos C., Bardies M., Bax J., et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 32 (2005) 855-897
3. Berman D.S., Kiat H.S., Van Train K.F., Germano G., Maddahi J., and Friedman J.D. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 35 (1994) 681-688
4. Henzlova M.J., Cerqueira M.D., Mahmarian J.J., and Yao S.S. Stress protocols and tracers. J Nucl Cardiol 13 (2006) e80-e90
5. Berman D.S., Kiat H., Friedman J.D., Wang F.P., van Train K., Matzer L., et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22 (1993) 1455-1464
6. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of Radioactive Substances Advisory Committee. Nucl Med Commun 21 Suppl (2000) S1-S93
7. Culver C.M., and Dworkin H.J. Comparison of personnel radiation dosimetry from myocardial perfusion scintigraphy: technetium-99m-sestamibi versus thallium-201. J Nucl Med 34 (1993) 1210-1213
8. Wackers F.J., Berman D.S., Maddahi J., Watson D.D., Beller G.A., Strauss H.W., et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30 (1989) 301-311
9. van Dongen A.J., and van Rijk P.P. Minimizing liver, bowel, and gastric activity in myocardial perfusion SPECT. J Nucl Med 41 (2000) 1315-1317
10. Germano G., Chua T., Kiat H., Areeda J.S., and Berman D.S. A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 35 (1994) 356-359
11. Hofman M., McKay J., and Nandurkar D. Efficacy of milk versus water to reduce interfering infra-cardiac activity in 99mTc-sestamibi myocardial perfusion scintigraphy. Nucl Med Commun 27 (2006) 837-842
12. Iqbal S.M., Khalil M.E., Lone B.A., Gorski R., Blum S., and Heller E.N. Simple techniques to reduce bowel activity in cardiac SPECT imaging. Nucl Med Commun 25 (2004) 355-359
13. Peace R.A., and Lloyd J.J. The effect of imaging time, radiopharmaceutical, full fat milk and water on interfering extra-cardiac activity in myocardial perfusion single photon emission computed tomography. Nucl Med Commun 26 (2005) 17-24
14. Boz A., Gungor F., Karayalcin B., and Yildiz A. The effects of solid food in prevention of intestinal activity in Tc-99m tetrofosmin myocardial perfusion scintigraphy. J Nucl Cardiol 10 (2003) 161-167
15. Boz A., and Karayalcin B. Which is better for inferior wall evaluation: a full or empty stomach?. J Nucl Med 37 (1996) 1916-1917
16. Boz A., Yildiz A., Gungor F., Karayalcin B., and Erkilic M. The volume effect of the stomach on intestinal activity on same-day exercise-rest Tc-99m tetrofosmin myocardial imaging. Clin Nucl Med 26 (2001) 622-625
17. Matsumoto N., Sato Y., Suzuki Y., Yoda S., Kunimasa T., Kato M., et al. Usefulness of rapid low-dose/high-dose 1-day 99mTc-sestamibi ECG-gated myocardial perfusion single-photon emission computed tomography. Circ J 70 (2006) 1585-1589
18. Lewin H.C., Hyun M.E., DePuey E.G., and Schisterman E. Validation of a very rapid rest/stress 1-day Tc-99m sestamibi stress protocol. [abstract]. J Nucl Cardiol 10 (2003) S24
19. Sakata Y., Nishimura T., Yamazaki J., Nishimura S., Kaivyas T., Kodama K., et al. Diagnosis of coronary artery disease by thallium-201 myocardial scintigraphy with intravenous infusion of SUNY4001 (adenosine) in effort angina pectoris-the clinical trial report at multi-center: phase II. [in Japanese]. Kaku Igaku 41 (2004) 123-132
20. Rehm P.K., Atkins F.B., Ziessman H.A., Green S.E., Akin E.A., Fox L.M., et al. Frequency of extra-cardiac activity and its effect on 99Tcm-MIBI cardiac SPET interpretation. Nucl Med Commun 17 (1996) 851-856
21. Acampa W., Cuocolo A., Sullo P., Varrone A., Nicolai E., Pace L., et al. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 5 (1998) 265-274
22. Palmas W., Friedman J.D., Diamond G.A., Silber H., Kiat H., and Berman D.S. Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol 25 (1995) 1024-1031
23. Hambye A.S., Vervaet A., Lieber S., and Ranquin R. Diagnostic value and incremental contribution of bicycle exercise, first-pass radionuclide angiography, and 99mTc-labeled sestamibi single-photon emission computed tomography in the identification of coronary artery disease in patients without infarction. J Nucl Cardiol 3 (1996) 464-474